Company: INDP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010099
Chunk: 27

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 27
---

     -  
     774,691  
     -  
     774,691 
  
    Issuance of shares of common stock, net of issuance costs 
     137,836  
     1,378  
     314,669  
     -  
     316,047 
  
    Net loss 
     -  
     -  
     -  
     (3,806,677) 
     (3,806,677)
  
    Balance, March 31, 2024 
     8,538,883  
    $85,389  
    $58,499,003  
    $(49,223,833) 
    $9,360,559 

    Balance, January 1, 2025 
     12,013,901  
    $120,139  
    $64,263,919  
    $(60,439,183) 
    $3,944,875 
  
    Balance 
     12,013,901  
    $120,139  
    $64,263,919  
    $(60,439,183) 
    $3,944,875 

    Stock-based compensation 
     -  
     -  
     240,891  
     -  
     240,891 
  
    Issuance of shares of common stock and warrants, net of issuance costs (Note 6b) 
     2,109,383  
     21,094  
     1,965,650  
     -  
     1,986,744 
  
    Issuance of shares of common stock, net of issuance costs (Note 6c) 
     1,605,200  
     16,052  
     1,143,599  
     -  
     1,159,651 
  
    Issuance of commitment shares (Note 6c) 
     305,960  
     3,059  
     (3,059) 
     -  
     - 
  
    Net loss 
     -  
     -  
     -  
     (4,532,430) 
     (4,532,430)
  
    Balance, March